Company Filing History:
Years Active: 2003-2005
Title: Martin Wikberg: Innovator in Controlled Release Technologies
Introduction
Martin Wikberg is a notable inventor based in Kullavik, Sweden. He has made significant contributions to the field of controlled release formulations, holding a total of 3 patents. His work focuses on innovative methods and formulations that enhance the delivery of active ingredients in therapeutic applications.
Latest Patents
Wikberg's latest patents include a controlled release bead and a therapeutic formulation for administering tolterodine. The controlled release bead consists of a core unit made of a substantially water-soluble or water-swellable inert material, layered with a water-insoluble polymer and an active ingredient. This design effectively controls the release of the active ingredient by managing water penetration into the core. Additionally, his patent for a therapeutic formulation addresses the treatment of unstable or overactive urinary bladders using tolterodine, ensuring a consistent serum level of the active compound for at least 24 hours.
Career Highlights
Throughout his career, Martin Wikberg has worked with prominent companies such as Pharmacia AB and Pfizer Health AB. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical formulations.
Collaborations
Wikberg has collaborated with notable colleagues, including Anders Ringberg and Torkel Gren. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Martin Wikberg's contributions to controlled release technologies demonstrate his commitment to improving therapeutic formulations. His innovative patents and collaborations highlight his role as a significant figure in the field of pharmaceutical sciences.